Show Summary Details
Page of

Nasopharyngeal carcinoma 

Nasopharyngeal carcinoma
Nasopharyngeal carcinoma

Suat W. Loo

and Tom Roques

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 19 January 2021

The majority of patients with nasopharyngeal carcinoma present with stage III or IV disease. Radiotherapy to a curative dose with concurrent platinum-based chemotherapy is the standard of care in the management of this group of patients. Despite this, a significant proportion will develop local tumour recurrence. Early-stage local recurrences can be managed with salvage nasopharyngectomy, intracavitary brachytherapy or interstitial implants. In those with locally advanced recurrent tumours, re-irradiation with external-beam radiotherapy represents the only potentially curative treatment option. With careful patient selection, long-term survival can be achieved.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.